Chalene Johnson recorded this one on the road, starting in New York and wrapping up in Paros, Greece, and it might be one of the most information-packed episodes she's done all year.
There's a comparison being made right now that Chalene can't stop thinking about. Two women, both 32, both at the height of their careers. One of them died. The parallels today are ones she felt compelled to address out loud, even without easy answers.
Then a study just dropped from Northwestern Medicine that reframes the entire perimenopause and brain fog conversation, and it has nothing to do with hot flashes. If you've ever walked into a room and forgotten why you're there, this research explains something your doctor probably never mentioned.
Plus, brand new data from Fitbits and Apple Health devices reveals what's actually happening to people on GLP-1 medications that nobody is talking about yet. And a Stanford study just identified a compound that could change the muscle loss conversation entirely.
Chalene also gives you a heads up on a deeply disturbing documentary trending on Netflix right now and why she wants you to watch it before Friday.
🚨Questions Chalene Wants Your Thoughts on:
💪🏼 Need a clinician who is trained in women's health and accepts insurance? Book your virtual visit today with MIDI Health! 👉http://chalene.com/midi
🔥 Related Links:
🔥Join Chalene on her private podcast 👉http://chalene.com/more
🧐Sign Up to Get the Weekly Newsletter!! 👉https://chalene.com/newsletter/
🎉 Camp Be More 2027 Registration is now OPEN!! 👉 http://campbemore.com
🎯Our Sponsors!!
🔥 Join Phase It!! Simplifies the art of aging vibrantly with science-backed fitness, nutrition and hormone support programs that actually work! https://phaseitup.com/
Join the PodSquad on Facebook! 👉https://www.facebook.com/groups/ChalenePodSquad
We would love to hear from you! Leave your questions or messages for Chalene RIGHT HERE
To advertise on our podcast, please reach out to thechaleneshow@gmail.com and mention The Chalene Show
Connect with me on your fav social platform: